Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study

M. Fajfr, M. Louda, P. Paterová, L. Ryšková, J. Pacovský, J. Košina, H. Žemličková, M. Broďák,

. 2017 ; 17 (1) : 33. [pub] 20170426

Language English Country Great Britain

Document type Journal Article

BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic. METHOD: In this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation. RESULTS: The most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease. CONCLUSION: We have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010638
003      
CZ-PrNML
005      
20180418095931.0
007      
ta
008      
180404s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12894-017-0222-6 $2 doi
035    __
$a (PubMed)28446177
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Fajfr, Miroslav $u Institute of Clinical Microbiology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic. miroslav.fajfr@fnhk.cz. Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic. miroslav.fajfr@fnhk.cz.
245    14
$a The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study / $c M. Fajfr, M. Louda, P. Paterová, L. Ryšková, J. Pacovský, J. Košina, H. Žemličková, M. Broďák,
520    9_
$a BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic. METHOD: In this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation. RESULTS: The most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease. CONCLUSION: We have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase.
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    _2
$a Česká republika $7 D018153
650    _2
$a fosfomycin $x farmakologie $7 D005578
650    _2
$a gramnegativní bakterie $x účinky léků $x izolace a purifikace $7 D006090
650    _2
$a lidé $7 D006801
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a infekce močového ústrojí $x mikrobiologie $7 D014552
650    _2
$a beta-laktamasy $7 D001618
655    _2
$a časopisecké články $7 D016428
700    1_
$a Louda, Miroslav $u Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic. Clinic of Urology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic.
700    1_
$a Paterová, Pavla $u Institute of Clinical Microbiology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic. Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic.
700    1_
$a Ryšková, Lenka $u Institute of Clinical Microbiology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic. Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic.
700    1_
$a Pacovský, Jaroslav $u Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic. Clinic of Urology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic.
700    1_
$a Košina, Josef $u Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic. Clinic of Urology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic.
700    1_
$a Žemličková, Helena $u Institute of Clinical Microbiology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic. Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic.
700    1_
$a Broďák, Miloš $u Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic. Clinic of Urology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic.
773    0_
$w MED00008208 $t BMC urology $x 1471-2490 $g Roč. 17, č. 1 (2017), s. 33
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28446177 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180418100030 $b ABA008
999    __
$a ok $b bmc $g 1288123 $s 1007450
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 17 $c 1 $d 33 $e 20170426 $i 1471-2490 $m BMC urology $n BMC Urol $x MED00008208
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...